Home » Newsletters » BioWorld

BioWorld

Jan. 28, 1992

View Archived Issues

GYNEX TO USE VA DATA IN FDA REVIEW

CYTRX TO REDEEM CLASS B WARRANTS

UNIGENE PLANS CALCITONIN SALES

DNAP TO ACQUIRE JOINT VENTURE

YAMANOUCHI TO SELL ABS TEST KITS

STEM CELL CONCENTRATOR SUCCESSFUL IN TESTS

INSITE TO EYE SYNERGEN'S ANTRIL

CARRINGTON REPORTS PROFITABLE YEAR

BUSH TO DISCUSS BIOTECH INITIATIVE

AMYLIN RECEIVES FIRST PATENT NOTICE

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...